Where it comes from
- Made in
- The same cells as neurotensin, cut from the same precursor
- Sent out by
- With neurotensin
- Acts on
- Neurotensin receptors
What it does
- Acts like neurotensin at the same receptors, and is destroyed in seconds in blood 1
- Shares neurotensin’s last three residues, which is the part the receptors read, and that is why the two cannot easily be told apart by their effects
- Studied in the brain for its effects on dopamine, pain and body temperature, always alongside neurotensin rather than instead of it 2
In medicine
- None of its own: no medicine, and no clinical assay measures it
- The blood test used in cohort studies measures pro-neurotensin, the uncut precursor the two peptides come from, so published “neurotensin” risk associations belong to both
Beyond the body’s own use
- Not studied as a treatment. It was identified in pig spinal cord in 1984 and has had no programme of its own since 1
- What is genuinely unknown is whether it does anything the longer peptide does not. Because it is cleared faster and binds more weakly, it may be no more than a second product of the same cut; nobody has made a stable version to find out 2
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.